Hemant Surgical Industries Share Price
373.00+4.35 (+1.18%)
+23.59% past 1 Year
Hemant surgical Industries Limited is engaged in the business of manufacturing, importing, assembly and marketing of medical equipments and disposables. Its product offerings cover a wide spectrum of equipment and
Corporate filings & documents
Announcements
Newspaper Advertisement for Notice of AGM to be held through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).
4 days agoNewspaper Advertisement for Notice of AGM to be held through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).
4 days agoThe Company has considered and decided to hold AGM of the Company on September 29 2026 through VC/OAVM.
6 days agoThe Company has considered and decided to hold AGM of the Company on September 29 2026 through VC/OAVM.
6 days agoCertificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026
1 month agoCertificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026
1 month agoIn continuation to disclosure dated March 31 2026 minor modification have been made in attached disclosure.
2 months agoPlease find enclosed Press Release being issued by the Company titled "Hemant Surgical Strengthens Healthcare Portfolio through Strategic Acquisition of Majority Stake in Lifesenz Cancer Research Labs".
2 months agoWith reference to intimation dated May 27 2026 the Company has completed the acqusition of Lifesenz Cancer Labs Private Limited and has become subsidiary of the Company w.e.f. June 01 2026.
3 months agoNon-Applicability of Annual Secretarial Compliance Report for the Financial Year Ended March 31 2026
3 months agoNon-Applicability of Annual Secretarial Compliance Report for the Financial Year Ended March 31 2026
3 months agoThe Company at its meeting held today i.e. May 27 2026 has entered into Share Purchase Agreement (SPA) for acquisition of 66.66% equity shareholding of Lifesenz Cancer Labs Private Limited Mumbai.
3 months agoThe Company at its meeting held today i.e. May 27 2026 has entered into Share Purchase Agreement (SPA) for acquisition of 66.66% equity shareholding of Lifesenz Cancer Labs Private Limited Mumbai.
3 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Singularity Equity Fund I
3 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Singularity Equity Fund I
3 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Singularity Large Value Fund III
3 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Singularity Large Value Fund III
3 months agoAllotment of 14 99 200 Equity Shares consequent to conversion of Convertible Warrants
3 months agoAllotment of 14 99 200 Equity Shares consequent to conversion of Convertible Warrants
3 months agoThe Board of Directors at its meeting held today has appointment M/s. K Sorathiya & Co Practicing Cost Accountants as Cost Auditor of the Company for F.Y. 26-27
3 months agoThe Board of Directors at its meeting held today has appointment M/s. K Sorathiya & Co Practicing Cost Accountants as Cost Auditor of the Company for F.Y. 26-27
3 months agoThe Board of Directors at its Meeting held today has appointed M/s. A D M S and Company Chartered Accountant as Internal Auditor of the Company for F.Y. 26-27
3 months agoThe Board of Directors at its Meeting held today has appointed M/s. NKM & Associates as Secretarial Auditor of the Company for F.Y. 26-27
3 months agoThe Board of Directors at its Meeting held today has appointed M/s. NKM & Associates as Secretarial Auditor of the Company for F.Y. 26-27
3 months agoAudited Financial Results of the Company for half and financial year ended March 31 2026
3 months agoAudited Financial Results of the Company for half and financial year ended March 31 2026
3 months agoThe Board of Directors at its meeting held today have approved Audited Financial Results of the Company for half and financial year ended March 31 2026
3 months agoThe Board of Directors at its meeting held today have approved Audited Financial Results of the Company for half and financial year ended March 31 2026
3 months agoHemant Surgical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the half year and financial year ended March 31 2026.
3 months agoCertificate under Regulation 74(5) of the SEBI (DP) Regulations 2018 for the quarter ended March 31 2026.
5 months agoCertificate under Regulation 74(5) of the SEBI (DP) Regulations 2018 for the quarter ended March 31 2026.
5 months agoThe Company has executed C-ARM Development and Supply Agreement with GBT Korea Co Ltd Republic of Korea.
5 months agoThe Company has executed C-ARM Development and Supply Agreement with GBT Korea Co Ltd Republic of Korea.
5 months agoThe Company has entered into Strategic Semi Knocked Down (SKD) Manufacturing Agreement with Sonomed Escalon USA
5 months agoIntimation of Closure of Trading Window
5 months agoIntimation of Closure of Trading Window
5 months agoIntimation of receipt of purchase order from Central Medical Services Society Ministry of Health and Family Welfare (Government of India).
6 months agoCertificate under Reg. 74(5) of SEBI (DP) Regulation 2018.
7 months agoStatement of Deviation or Variation for half year ended on September 30 2025
9 months agoStatement of Deviation or Variation for the half year ended on September 30 2025.
9 months agoUnaudited financial results of the Company for the half year ended on September 30 2025.
9 months agoOutcome of Board Meeting held on Wednesday November 12 2025 pursuant to Regulations 30 33 and other applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
9 months agoHemant Surgical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve unaudited financial results of the Company for half year ended on September 30 2025
10 months agoCertificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended September 30 2025.
10 months agoIntimation regarding closure of trading window
11 months agoProceedings and Scrutinizer report of the 36th Annual General Meeting (AGM) of Hemant Surgical Industries Limited ("the Company") held on Tuesday September 23 2025.
11 months agoProceedings and Voting Results of the 36th Annual General Meeting (AGM) of Hemant Surgical Industries Limited (the Company) held on Tuesday September 23 2025.
11 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hanskumar Shamji Shah & Others
11 months agoAllotment of 25 98 400 Equity Shares on Preferential basis
11 months agoIntimation under Regulation 30 of SEBI LODR Regulation 2015 Allotment of 20 99 200 Warrants on Preferential basis
11 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2021-09-15
Dividend
4.0
2020-09-09
Dividend
3.0
2019-08-19
Dividend
3.0
2018-08-23
Dividend
4.0
2017-07-20
Dividend
4.0
2016-08-30
Dividend
4.0
2015-09-14
Dividend
3.5
2014-09-18
Dividend
3.0
2013-09-20
Dividend
3.0
2012-09-07
Dividend
3.0
2011-09-09
Dividend
2.5
2010-09-08
Dividend
2.0
Company details
Registered office
502,5th Floor, Ecstasy Business Park Co-op Socteiy Limited, J. S. D. Road Mulund (West) Mumbai Maharashtra PIN: 400080 Tel No: 022-25915289 / 25912747 Fax No: 022-22077585 / 22064684 Email: [email protected] / [email protected] Internet: www.hemantsurgical.com
Registrars
Office No S6-2, 6th Floor, Pinnacle Business Park,ext to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093(old address - Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059Tel: + 91 21 626 38200Fax: Office No S6-2, 6th Floor, Pinnacle Business Park Next to Ahura Centre, Mahakali Caves Road Andheri (E) PIN: Tel No: 91-022-62638200 Fax No: 91-022-62638299 Email: [email protected]
Management
Hanskumar Shamji Shah, Chairman & Managing Director
Hanskumar Shamji Shah, Chairman & Managing Director
Kaushik Shah, Whole Time Director & Chief Financial Officer
Hemant Praful Shah, Whole Time Director
Nehal Babu Karelia, Non Executive Director
Ketan Dave, Non Executive Independent Director
Kshama Ronak Dharnidharka, Non Executive Independent Director
Meenal Ajmera, Company Secretary & Compliance Officer
Details
BSE 543916
NSE NULL
ISIN INE0GYI01028